Apollo Hospitals, Mumbai – India
About Dr. Rajesh Shinde
Dr. Rajesh Shinde is a highly distinguished leading Surgical Oncologist in India. With over a decade of dedicated service in oncology, Dr. Shinde is renowned for his expertise in managing complex cancers of the gastrointestinal tract, liver, and pancreas. He is particularly noted for his proficiency in advanced Robotic Surgery and Minimally Invasive techniques, offering patients better outcomes with faster recovery times.
Trained at the prestigious Tata Memorial Hospital in Mumbai, Dr. Shinde brings a wealth of academic and clinical rigor to his practice. He has further honed his skills through international fellowships in GI and Robotic surgery in South Korea and Verona, Italy. His clinical focus lies in treating stomach, colorectal, pancreatic, and oesophageal cancers, alongside performing cytoreductive surgeries (HIPEC/PIPAC) for advanced abdominal malignancies. Dr. Shinde is celebrated not just for his surgical precision, but for his patient-centric approach and significant contributions to cancer research.
Qualifications & Credentials
Medical Degrees:
- MBBS
- MS (General Surgery)
- M.Ch (Surgical Oncology)
- Fellowship in Advanced GI & Robotic Surgery: South Korea (Awarded RD Birla Smarak Kosh Scholarship).
- ESSO Training Fellowship: University of Verona, Italy (Focus on Pancreatic & GI malignancies).
- Robotic Surgery Training: Da Vinci Xi System certification for colorectal and abdominal procedures.
- FACS: Fellow of the American College of Surgeons (inferred from professional standing).
- Registered with the Medical Council of India/Maharashtra Medical Council.
Areas of Expertise
Major Cancer Types Treated:
- Colorectal Cancer (Colon & Rectal Tumours)
- Pancreatic Cancer
- Liver Cancer (Hepatocellular Carcinoma & Metastases)
- Stomach (Gastric) Cancer
- Oesophageal Cancer
- Gallbladder & Bile Duct Cancer
- Peritoneal Surface Malignancies
- Robotic GI Surgery
- Hepato-Pancreato-Biliary (HPB) Surgery
- Minimally Invasive (Laparoscopic) Oncology
- Thoracic Oncology (VATS)
- Sphincter Preservation Surgery (for Rectal Cancer)
- Robotic Low Anterior Resection & APR
- Whipple’s Procedure (Pancreaticoduodenectomy)
- Major Liver Resections (Hepatectomy)
- Cytoreductive Surgery (CRS) + HIPEC (Hyperthermic Intraperitoneal Chemotherapy)
- PIPAC (Pressurised Intraperitoneal Aerosol Chemotherapy)
- Robotic Esophagectomy
List of Disease and Treatment for which Dr. Rajesh Shinde can be consulted
Professional Experience
Current & Past Hospital AffiliationsCurrent Affiliation:
- Lead Consultant - Surgical Oncology, Apollo Hospitals, Navi Mumbai (Since Feb 2020)
- Consultant, Surgical Oncology, Bombay Hospital Institute of Medical Sciences, Mumbai (2019 – 2020)
- Specialist Registrar / Fellow, Tata Memorial Hospital, Mumbai (2013 – 2019)
- Resident, Bombay Hospital Institute of Medical Sciences (2008 – 2013)
- Integral part of the team at Tata Memorial Hospital that performed and analyzed 1,200 consecutive Pancreatoduodenectomies, contributing to the establishment of Centres of Excellence in India.
- Pioneered the use of Robotic Surgery for rectal cancers at Apollo Navi Mumbai, significantly improving sphincter preservation rates.
- Awarded the prestigious RD Birla Smarak Kosh Scholarship for higher training in GI Surgery in South Korea.
- Instrumental in implementing ERAS (Enhanced Recovery After Surgery) protocols for major GI cancer surgeries, reducing hospital stay durations.
Awards & Recognitions
National & International Awards:
- Best Paper Award (Oral Presentation): NATCON 2019, Kolkata.
- CSCO Travel Grant: To present at the Annual CSCO Meeting in Xiamen, China (2018).
- ESSO Training Fellowship Grant: For training at the University of Verona (2018).
- IASO Travel Grant: To present a poster at the Annual SSO Meeting in Chicago, USA (2018).
- Best Poster Award: IASG 2017, Pondicherry.
- Best Paper Award: ICC 2017, Bangalore.
- Member, ASCO (American Society of Clinical Oncology).
- Member, SSAT (Society for Surgery of the Alimentary Tract).
- Member, IASO (Indian Association of Surgical Oncology).
- Member, AMASI (Association of Minimal Access Surgeons of India).
Research & Publications
Published Papers in Medical Journals:
- Robotic Total Mesorectal Excision-Stepwise Narrative (Article, 2025)
- 1200 Consecutive Pancreatoduodenectomies from Single Centre: Impact of Evolving Centre of Excellence on Pancreatic Cancer Surgery across India (World Journal of Surgery, 2019)
- Cutting edge strategies for borderline resectable pancreatic cancer (Annals of Gastroenterological Surgery, 2019)
- Pelvic exenteration with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS+ HIPEC) for rectal cancer (Indian Journal of Surgical Oncology, 2019)
- Pulmonary metastatectomy of colorectal cancer origin: Evaluating process and outcomes (Journal of Surgical Oncology, 2018)
- Impact of histological subtype on treatment outcome in post NACTRT locally advanced rectal adenocarcinoma (Acta Oncologica, 2018)
- Robotic Transabdominal Intersphincteric Resection (ISR) and Stapled Coloanal Anastomosis with the da Vinci Xi System (Colorectal Disease, 2018)
- Gastroenteropancreatic Neuroendocrine Tumors (Chapter, 2024)
Patient Success Stories & Testimonials
Successful Robotic Surgery for Rectal Cancer
- Patients diagnosed with low rectal cancers often fear permanent colostomy bags. Dr. Shinde has successfully performed numerous robotic intersphincteric resections, allowing patients to retain natural bowel function. These patients frequently praise the "scarless" nature of the surgery and the rapid return to normalcy.
- Cases involving pancreatic tumours are notoriously difficult. Patients operated on by Dr. Shinde for pancreatic head tumours cite his meticulous pre-operative planning and the transparent communication regarding risks. Post-operative care under his supervision is often described as "reassuring" and "thorough."
- Patients undergoing Cytoreductive Surgery and HIPEC for peritoneal malignancies often express gratitude for Dr. Shinde's willingness to tackle advanced disease. Testimonials highlight his ability to provide hope and extended quality of life where other treatments had limited scope.
Treatment Approach & Philosophy
- Patient-Centred Care: Dr. Shinde adopts a holistic approach, ensuring that the treatment plan is tailored to the individual's biology and personal needs. He believes in "organ preservation" whenever possible and prioritises the patient's quality of life alongside oncological clearance.
- Technology & Innovation: As a proponent of modern oncology, Dr. Shinde leverages Robotic Surgery (da Vinci Xi) and Laparoscopic techniques to minimise trauma. He stays at the forefront of medical science, incorporating advanced therapies like HIPEC and PIPAC for advanced cancers, ensuring his patients have access to global standards of care.
Treatment Costs
Treatment costs vary depending on the stage of cancer, the type of surgery (Robotic vs Open), and the patient's general health. Below is an estimated cost table for procedures performed by Dr. Rajesh Shinde.
Note: For appointment booking and to get a personalised cost estimate, you can connect with the Cancer Rounds team.
| Treatment / Procedure | Cost Estimate (INR) | Cost Estimate (USD) |
| Robotic Colorectal Surgery | ₹4,50,000 - ₹6,50,000 | $5,400 - $7,800 |
| Whipple’s Procedure (Pancreatic Cancer) | ₹5,00,000 - ₹7,50,000 | $6,000 - $9,000 |
| Hepatectomy (Liver Resection) | ₹4,00,000 - ₹6,00,000 | $4,800 - $7,200 |
| CRS + HIPEC (Peritoneal Cancer) | ₹6,00,000 - ₹9,00,000 | $7,200 - $10,800 |
| VATS (Thoracic Surgery) | ₹3,50,000 - ₹5,00,000 | $4,200 - $6,000 |
| Robotic Esophagectomy | ₹5,50,000 - ₹7,50,000 | $6,600 - $9,000 |
International Patient Assistance
- Language Support: The Cancer Rounds team provides professional interpretation services to bridge any language gaps, ensuring international patients fully understand their diagnosis and surgical plan.
- Visa & Travel Assistance: Cancer Rounds offers end-to-end support, including assistance with Medical Visas, airport transfers, and arranging comfortable accommodation near Apollo Hospitals Navi Mumbai for patients and their attendants.
- Pre-treatment Virtual Consultations: International patients can book a video consultation with Dr. Rajesh Shinde via Cancer Rounds to discuss their medical reports and determine the feasibility of surgery before travelling.
Frequently Asked Questions
Dr. Rajesh Shinde is a leading surgical oncologist in India specialising in Gastrointestinal (GI) oncology, HPB (Liver, Pancreas) surgery, and Thoracic cancers. He is an expert in Robotic and Minimally Invasive surgeries.
Dr. Shinde has over 10 years of experience in the field of Surgical Oncology, with extensive training at Tata Memorial Hospital and international fellowships.
Yes, Dr. Shinde is highly proficient in Robotic Surgery using the da Vinci Xi system, particularly for colorectal, esophageal, and gastric cancers, offering patients precise outcomes and faster recovery.
HIPEC stands for Hyperthermic Intraperitoneal Chemotherapy. It is a procedure used for advanced abdominal cancers. Dr. Shinde is skilled in performing Cytoreductive Surgery (CRS) combined with HIPEC for peritoneal malignancies.
He completed his M.Ch in Surgical Oncology at the renowned Tata Memorial Hospital, Mumbai. He also holds fellowships from the University of Verona (Italy) and specialised GI surgery training from South Korea.
Yes, Dr. Shinde regularly treats patients from around the world. Cancer Rounds assists these patients with logistics, appointments, and travel arrangements.
Dr. Rajesh Shinde is currently the Lead Consultant in Surgical Oncology at Apollo Hospitals, Navi Mumbai.
HPB surgery covers cancers of the Liver, Pancreas, Gallbladder, and Bile Ducts. Dr. Shinde performs complex resections like Whipple’s procedure and Hepatectomies for these conditions.
You can schedule a consultation or a second opinion with Dr. Rajesh Shinde by contacting the Cancer Rounds team, who will facilitate the review of your medical records.
Yes, Dr Rajesh Shinde holds memberships in prestigious organisations such as ASCO (USA), SSAT (USA), and ESSO (Europe), reflecting his standing in the global oncological community.
Jaslok Hospital - India
Stomach Cancer (Gastric Cancer)
